Osteomalacia is a weakening of the bones. When not treated, it can lead to serious health complications, such as fractures and severe deformity. Here, we look at causes, symptoms, diagnosis ...

Osteomalacia is more common in women and often happens during pregnancy. It’s not the same as osteoporosis. Both can cause bones to break.

Diagnosis Tumor-induced osteomalacia. Management The patient received phosphate and vitamin D supplementation in the form of potassium-phosphorus (500 mg, three times daily) ...

OSTEOMALACIA is a generalized disease of bone characterized by lack of calcification of a presumably normal osteoid matrix. The chemical changes in the serum are usually diagnostic and consist of a ...

Tumour-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a rare paraneoplastic disorder caused by tumours that secrete fibroblast growth factor 23 (FGF23). Owing to the role of ...

In oncogenic osteomalacia, tumor tissue is the major source of FGF-23, as previously shown by the abundant amounts of FGF-23 mRNA and protein produced by these often remarkably small and hard-to ...

Tumor-induced osteomalacia is a rare disease in which small tumors produce fibroblast growth factor 23 (FGF23), leading to phosphate wasting and impaired vitamin D News News CME CME ...

Did you know that certain medications can cause symptom of 'Osteomalacia'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.

Chest, ankle, and hip pain are presented in a previously healthy 32-year-old man whose unusual, persistent musculoskeletal symptoms pointed to tumor-induced osteomalacia. How is this diagnosis made?

Sidebar: Pathogenesis and Consequences of Renal Phosphate Wasting Osteomalacia Syndromes Pathogenesis. TIO: tumoral secretion of phosphatonins (e.g. FGF-23, sFRP-4, MEPE, FGF-7) overwhelms the ...